Stocks · Industrials · Services-Testing Laboratories

NEOGENOMICS INC

NEO Clue Score37
United States Fiscal year ends December CIK 0001077183 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Lynn A. Tetrault
15 Jun 2026
Director
Sold on a plan
5,307
$11.10
$58.91K
Lynn A. Tetrault
9 Jun 2026
Director
Sold on a plan
5,307
$11.29
$59.92K
Warren Stone
20 Jan 2026
Pres & Chief Operating Officer
Sold on a plan
22,128
$12.50
$276.68K
Alicia C Olivo
16 Oct 2025
EVP, GC & Business Development
Sold on a plan
4,918
$10.00
$49.18K
Alicia C Olivo
15 Nov 2024
General Counsel
Sold on a plan
5,175
$15.36
$79.48K
Alicia C Olivo
15 Aug 2024
General Counsel
Sold on a plan
1,040
$16.05
$16.70K
Alicia C Olivo
15 May 2024
General Counsel
Sold on a plan
1,049
$15.74
$16.51K
Lynn A. Tetrault
4 Mar 2024
Director
Sold on a plan
6,112
$15.97
$97.58K
Alicia C Olivo
15 Feb 2024
General Counsel
Sold on a plan
2,587
$14.96
$38.71K
Alicia C Olivo
17 Nov 2023
General Counsel
Sold on a plan
2,669
$18.39
$49.08K

What was left out

Form 4 filings counted 395
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 43
Sales at will 87
Transactions with no price 0
Shares from compensation/vesting 9,474,898
Sales filed before the plan box existed 86
History held since 9 May 2011